Issues Related to Distribution and Sale of Pharmaceutical and Medical Products and Services; Drug Pricing Issues: Prescription Drug Abuse Issues.
Issues Related to Distribution and Sale of Pharmaceutical and Medical Products and Services;
Issues Related to Distribution and Sale of Pharmaceutical and Medical Products and Services; Center for Medicare and Medicaid Innovation (CMMI); CMS Bundled Payment Programs; and Bundled Payments for Care Improvement (BPCI) Initiative Models
Duration: January 16, 2017
to
December 3, 2018
General Issues: Health Issues , Pharmacy , Taxation/Internal Revenue Code , Medicare/Medicaid
Spending: about $135,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2017: U.S. Senate, House of Representatives, Health & Human Services - Dept of (HHS)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
4th Quarter, 2018
American Capitol Group terminated an engagement in which they represented Cardinal Health on Jan. 15, 2019.
Original Filing: 301004638.xml
3rd Quarter, 2018
In Q3, American Capitol Group lobbied for Cardinal Health , earning $20,000. The report was filed on Oct. 3, 2018.
Original Filing: 300982623.xml
Lobbying Issues
Issues Related to Distribution and Sale of Pharmaceutical and Medical Products and Services; Drug Pricing Issues: Prescription Drug Abuse Issues.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues Related to Distribution and Sale of Pharmaceutical and Medical Products and Services;
Agencies Lobbied
U.S. Senate
Type of Issue
Pharmacy/Internal Revenue Code
Lobbying Issues
Issues Related to Distribution and Sale of Pharmaceutical and Medical Products and Services; Center for Medicare and Medicaid Innovation (CMMI); CMS Bundled Payment Programs; and Bundled Payments for Care Improvement (BPCI) Initiative Models
Agencies Lobbied
U.S. Senate
2nd Quarter, 2018
In Q2, American Capitol Group lobbied for Cardinal Health , earning $25,000. The report was filed on July 9, 2018.
Original Filing: 300962962.xml
Lobbying Issues
Issues Related to Distribution and Sale of Pharmaceutical and Medical Products and Services; Drug Pricing Issues: Prescription Drug Abuse Issues.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues Related to Distribution and Sale of Pharmaceutical and Medical Products and Services;
Agencies Lobbied
U.S. Senate
Type of Issue
Pharmacy/Internal Revenue Code
Lobbying Issues
Issues Related to Distribution and Sale of Pharmaceutical and Medical Products and Services; Center for Medicare and Medicaid Innovation (CMMI); CMS Bundled Payment Programs; and Bundled Payments for Care Improvement (BPCI) Initiative Models
Agencies Lobbied
U.S. Senate
1st Quarter, 2018
In Q1, American Capitol Group lobbied for Cardinal Health , earning $25,000. The report was filed on April 12, 2018.
Original Filing: 300944105.xml
Lobbying Issues
Issues Related to Distribution and Sale of Pharmaceutical and Medical Products and Services; Drug Pricing Issues: Prescription Drug Abuse Issues.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues Related to Distribution and Sale of Pharmaceutical and Medical Products and Services;
Agencies Lobbied
U.S. Senate
Type of Issue
Pharmacy/Internal Revenue Code
Lobbying Issues
Issues Related to Distribution and Sale of Pharmaceutical and Medical Products and Services; Center for Medicare and Medicaid Innovation (CMMI); CMS Bundled Payment Programs; and Bundled Payments for Care Improvement (BPCI) Initiative Models
Agencies Lobbied
U.S. Senate
4th Quarter, 2017
In Q4, American Capitol Group lobbied for Cardinal Health , earning $15,000. The report was filed on Jan. 9, 2018.
Original Filing: 300921892.xml
Lobbying Issues
Issues Related to Distribution and Sale of Pharmaceutical and Medical Products and Services; Drug Pricing Issues: Prescription Drug Abuse Issues.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues Related to Distribution and Sale of Pharmaceutical and Medical Products and Services;
Agencies Lobbied
U.S. Senate
Type of Issue
Pharmacy/Internal Revenue Code
Lobbying Issues
Issues Related to Distribution and Sale of Pharmaceutical and Medical Products and Services; Center for Medicare and Medicaid Innovation (CMMI); CMS Bundled Payment Programs; and Bundled Payments for Care Improvement (BPCI) Initiative Models
Agencies Lobbied
U.S. Senate
3rd Quarter, 2017
In Q3, American Capitol Group lobbied for Cardinal Health . The report was filed on Oct. 19, 2017.
Original Filing: 300909188.xml
Lobbying Issues
Issues Related to Distribution and Sale of Pharmaceutical and Medical Products and Services; Drug Pricing Issues
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues Related to Distribution and Sale of Pharmaceutical and Medical Products and Services;
Agencies Lobbied
U.S. Senate
Type of Issue
Pharmacy/Internal Revenue Code
Lobbying Issues
Issues Related to Distribution and Sale of Pharmaceutical and Medical Products and Services; Center for Medicare and Medicaid Innovation (CMMI); CMS Bundled Payment Programs; and Bundled Payments for Care Improvement (BPCI) Initiative Models
Agencies Lobbied
U.S. Senate
2nd Quarter, 2017
In Q2, American Capitol Group lobbied for Cardinal Health , earning $25,000. The report was filed on July 6, 2017.
Original Filing: 300882416.xml
Lobbying Issues
Issues Related to Distribution and Sale of Pharmaceutical and Medical Products and Services;
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Internal Revenue Code
Lobbying Issues
Issues Related to Distribution and Sale of Pharmaceutical and Medical Products and Services; Center for Medicare and Medicaid Innovation (CMMI); CMS Bundled Payment Programs; and Bundled Payments for Care Improvement (BPCI) Initiative Models
Agencies Lobbied
U.S. Senate
2nd Quarter, 2017
American Capitol Group amended a lobbying report for representation of Cardinal Health in Q22017 on July 6, 2017.
Original Filing: 300882419.xml
Lobbying Issues
Issues Related to Distribution and Sale of Pharmaceutical and Medical Products and Services; Drug Pricing Issues
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues Related to Distribution and Sale of Pharmaceutical and Medical Products and Services;
Agencies Lobbied
U.S. Senate
Type of Issue
Pharmacy/Internal Revenue Code
Lobbying Issues
Issues Related to Distribution and Sale of Pharmaceutical and Medical Products and Services; Center for Medicare and Medicaid Innovation (CMMI); CMS Bundled Payment Programs; and Bundled Payments for Care Improvement (BPCI) Initiative Models
Agencies Lobbied
U.S. Senate
1st Quarter, 2017
In Q1, American Capitol Group lobbied for Cardinal Health , earning $25,000. The report was filed on April 5, 2017.
Original Filing: 300862786.xml
Lobbying Issues
Issues Related to Distribution and Sale of Pharmaceutical and Medical Products and Services;
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues/Internal Revenue Code
Lobbying Issues
Issues Related to Distribution and Sale of Pharmaceutical and Medical Products and Services; Center for Medicare and Medicaid Innovation (CMMI); CMS Bundled Payment Programs; and Bundled Payments for Care Improvement (BPCI) Initiative Models
Agencies Lobbied
U.S. Senate
1st Quarter, 2017
American Capitol Group filed a lobbying registration on Feb. 23, 2017 to represent Cardinal Health, effective Jan. 16, 2017.
Original Filing: 300860831.xml
Issue(s) they said they’d lobby about: Issues Related to Distribution and Sale of Pharmaceutical and Medical Products and Services;
Center for Medicare and Medicaid Innovation (CMMI);
CMS Bundled Payment Programs; and
Bundled Payments for Care Improvement (BPCI) Initiative Models .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...